Skip to content

A Randomized Controlled Trial of a 14-Day Mindfulness Ecological Momentary Intervention (MEMI) for Generalized Anxiety Disorder

Yeow Ai Tong, Michelle G Newman

preprint DOI: 10.31234/osf.io/t3egn (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial
Sample size 110
Population Adults with generalized anxiety disorder
Interventions Mindfulness ecological momentary intervention (MEMI) Self-monitoring placebo (SMP)
Duration 14-day intervention with assessments at baseline, post-treatment, and 1-month follow-up
Topics Anxiety Meditation
Key findings A 14-day unguided smartphone mindfulness intervention produced modest but potentially meaningful benefits over self-monitoring placebo for GAD severity, perseverative cognitions, trait mindfulness, and performance-based inhibition, with between-group effect sizes of roughly d = 0.28–0.39 at one-month follow-up and larger short-term effects (d = 0.50–1.13) on state anxiety, depression, and mindfulness immediately after treatment.

Abstract

Background: Little is known about whether brief mindfulness ecological momentary interventions (MEMI) yield clinically beneficial effects. This gap exists despite the rapid growth of smartphone mindfulness applications. Specifically, no prior brief MEMI has targeted generalized anxiety disorder (GAD). Moreover, although theories propose that MEMI can boost executive functioning (EF), they have largely gone untested. Thus, this randomized controlled trial (RCT) aimed to address these gaps by assessing the efficacy of a 14-day smartphone MEMI (vs. self-monitoring placebo (SMP)).

Method: Participants with GAD were randomly assigned to either condition (68 MEMI, 42 SMP). MEMI participants exercised multiple core mindfulness strategies and were instructed to practice mindfulness continually. Comparatively, SMP participants were prompted to practice self-monitoring and were not taught any mindfulness strategies. All prompts occurred five times a day for 14 consecutive days. Participants completed self-reports and neuropsychological assessments at baseline, post-treatment, and 1-month follow-up (1MFU). Piecewise hierarchical linear modeling analyses were conducted.

Results: MEMI (vs. SMP) produced greater pre-1MFU reductions in GAD severity and perseverative cognitions (between-group |d|=0.393–0.394) and stronger improvements in trait mindfulness and performance-based inhibition (|d|=0.280–0.303). Further, MEMI (vs. SMP) led to more considerable pre-post-treatment reductions in state-level depression and anxiety and more mindfulness gains (|d|=0.50–1.13). Overall, between-treatment effects were stronger at pre-1MFU than pre-post-treatment for trait-level than state-level treatment outcome measures.

Conclusions: Preliminary findings suggest that the beneficial effect of an unguided brief MEMI to target pathological worry, trait mindfulness, and EF is modest yet potentially meaningful. Other theoretical and clinical implications were discussed.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics